Case Study:
Using Large Language Models (LLMs) like ChatGPT to Speed Up Medical Literature Monitoring and Insights
How Large Language Models are helping medical affairs teams increase productivity and reduce medical literature monitoring time
The fastest growing bodies of content—in both volume and complexity—are in life sciences and healthcare. Analyzing this content (including clinical studies, publications, guidelines and more) and for medical insights will drive better decisions.
The Client
The client was spending significant time keeping up to date with monitoring and evaluating new medical content. This was a very resource-intense activity and they wanted a way to automate part of this.
The Solution
Using data-driven Natural Language Intelligence (including LLMs) to combine scale and flexibility with contextual understanding, and precision to provide content intelligence for deeper understanding and efficiency.
The Outcome
- Significant Increase in productivity (average from client estimate following implementation is 1000%)
- Significant decrease in literature monitoring time (average from client estimate following implementation is 82-92%)
- Vastly improved tracking to support portfolio products
To achieve these kinds of results, contact Eularis today.
Latest News
Read our latest blogs here.

We Have AI Initiatives. But, Do We Have a Strategy?
Every week, I speak with executives who tell me the same thing with the same mixture of pride and quiet unease: “We’re investing heavily in

Pharma’s Patent Cliff is Here. Why AI Strategy Matters Now More Than Ever.
The pharmaceutical industry is entering a decisive period. Over the next several years, many of its most valuable brands will lose exclusivity, putting a substantial

The Hidden Cost of Having No AI Strategy (Spoiler: It’s Not What You Think)
In the past few years, almost 70% of biopharma companies have initiated AI initiatives. Yet, fewer than 20% report a cohesive AI strategy at the